AGTRAP and glioblastoma: In addition, the abnormal protein expression of AGTRAP has been confirmed in the CPTAC samples across breast cancer, colon cancer, head and neck cancer, pancreatic cancer, glioblastoma multiforme, and hepatocellular carcinoma.